Peter Sjö
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Computational Drug Discovery Methods
Papers in
-
- SARS-CoV-2 and COVID-19 Research 8
- COVID-19 Clinical Research Studies 2
-
- Computational Drug Discovery Methods 5
- Co-authors
- Kyu‐Sung Jeong (1 shared paper)Karl Barry Sharpless (1 shared paper)Lena Ripa (4 shared papers)Igor L. Shamovsky (4 shared papers)Jan O. Kihlberg (4 shared papers)Stefan Schießer (3 shared papers)Charles E. Mowbray (3 shared papers)Glaucius Oliva (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (4 papers)Chemical Research in Toxicology (2 papers)ACS Infectious Diseases (2 papers)EBioMedicine (2 papers)Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry (2 papers)
- Partner nations
- SwitzerlandUnited KingdomSweden
In The Last Decade
Peter Sjö
35 papers receiving 838 citations
Peter Sjö's Hit Papers
Peers
Comparison fields: 5 of 85
- Infectious Diseases 255
- Computational Theory and Mathematics 171
- Cancer Research 62
- Organic Chemistry 139
- Pharmacology 29
Countries citing papers authored by Peter Sjö
This map shows the geographic impact of Peter Sjö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sjö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sjö more than expected).
Fields of papers citing papers by Peter Sjö
This network shows the impact of papers produced by Peter Sjö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sjö. The network helps show where Peter Sjö may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sjö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Hit paper breakdown → | 2023 | 126 |
| 2 | 2022 | 103 | |
| 3 | Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease Hit paper breakdown → | 2023 | 88 |
| 4 | 2011 | 70 | |
| 5 | 1992 | 52 | |
| 6 | 2023 | 52 | |
| 7 | 2020 | 40 | |
| 8 | 2018 | 37 | |
| 9 | 2012 | 29 | |
| 10 | 2022 | 29 | |
| 11 | 2012 | 23 | |
| 12 | 2023 | 23 | |
| 13 | 2020 | 22 | |
| 14 | 2022 | 21 | |
| 15 | 2014 | 20 | |
| 16 | 2017 | 19 | |
| 17 | 2024 | 17 | |
| 18 | 2022 | 14 | |
| 19 | 2010 | 11 | |
| 20 | 2022 | 11 |
About Peter Sjö
Peter Sjö is a scholar working on Infectious Diseases, Computational Theory and Mathematics, Organic Chemistry, Public Health, Environmental and Occupational Health and Cancer Research, having authored 36 papers that have together received 869 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Computational Drug Discovery Methods (5 papers), Research on Leishmaniasis Studies (3 papers), Metal-Catalyzed Oxygenation Mechanisms (3 papers), Mosquito-borne diseases and control (2 papers), Asymmetric Synthesis and Catalysis (2 papers), Trypanosoma species research and implications (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (255 citations), Computational Theory and Mathematics (171 citations), Cancer Research (62 citations), Organic Chemistry (139 citations) and Pharmacology (29 citations). Peter Sjö has collaborated with scholars based in Switzerland, United Kingdom and Sweden. Frequent co-authors include Kyu‐Sung Jeong, Karl Barry Sharpless, Lena Ripa, Igor L. Shamovsky, Jan O. Kihlberg, Stefan Schießer, Charles E. Mowbray, Glaucius Oliva, G.D. Noske and R.S. Fernandes. Their work appears in journals such as Journal of Medicinal Chemistry, Chemical Research in Toxicology, ACS Infectious Diseases, EBioMedicine and Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.